1. Introduction to COVID-19 Novel coronavirus (SARS-CoV-2) is a member of the enveloped RNA virus family, novel coronavirus, which was discovered at the end of 2019. This family of viruses includes MiddleRead More…
Science: RNA Vaccine makes claudin-CAR-T cells more effective against solid tumors
Adoptive T cell therapy has achieved clinical success in B cell malignant tumors. However, CAR-T cell therapy is challenged and less effective in patients with solid tumors. A key obstacle is theRead More…
Nature：Intravenous injection can significantly improve the efficacy of tuberculosis vaccine
Globally, although the vast majority of people have been vaccinated, more people die from TB than from any other infectious disease. Bacille Calmette-Guerin (BCG) is the only commercially available human tuberculosis vaccine.Read More…
High-dose Zika virus Vaccine can protect mothers and infants at the same time
Medical researchers at the University of Texas at Galveston have shown for the first time that a single higher dose of vaccination in a pregnant mouse can safely protect her and herRead More…
Tetravalent Influenza Vaccine approved by FDA in the United States
Recently, the US Food and Drug Administration (FDA) has approved an application for a supplementary biological product license from Sanofi’s Fluzone® High-Dose Quadrivalent (High dose tetravalent, Influenza Vaccine) for older people agedRead More…
Novel Nano-delivery System Makes Vaccine More Effective
1. RNA vaccine RNA-based vaccines have great potential as a way to treat cancer or prevent a variety of infectious diseases. As a result, many biotechnology companies are now developing this typeRead More…
New FDA Breakthrough Drug –Preventive of Respiratory Syncytial Virus (RSV) Advanced Vaccine
Janssen Pharmaceutical recently announced that the US Food and Drug Administration (FDA) has awarded the company the breakthrough drug qualification (BTD) for prophylactic RSV advanced vaccines. It is used to prevent lowerRead More…
Personalized cancer vaccine! Melanoma treatment vaccine TLPLDC reduces the risk of recurrence by 50%
Recently, Elios Therapeutics released positive top-line data to evaluate the clinical trial of TLPLDC (tumor lysate, particle loading, dendritic cell) vaccine in the treatment of melanoma in phase IIb. 1.Research result ThisRead More…
New Vaccine – Fight Two Fatal Respiratory Diseases
Recently, scientists at the Center for Infectious Diseases Research at the University of Adelaide in Australia have developed a single vaccination method. It can simultaneously fight two of the world’s deadliest respiratoryRead More…
HIV Prophylactic Vaccine! Patients in the “Mosaic Vaccine” Efficacy Verification Study Have Been Enrolled in the Study
Johnson (JNJ) of the United States recently announced that patients who evaluated the IIb phase proof-of-concept efficacy study Imbokodo (HVTN 705/HPX2008) of a prophylactic HIV vaccine have been enrolled. The study isRead More…